MENU
AVTE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Aerovate Therapeutics (AVTE) Ownership - Who owns Aerovate Therapeutics?
Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease... Show more
Profile
Industry
N/A
Address
930 Winter Street
Phone
+1 617 443-2400
Employees
51
Web
https://www.aerovatetx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.72B
P/E Ratio
N/A
Total Cash
3.96M
Projected Growth
N/A
Total Debt
417K
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.14
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
AVTE
Capitalization
N/A
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
N/A
Total Cash/Share
N/A
Total Debt
N/A
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
N/A
Revenue
N/A
ROE
N/A
Book Value
N/A
P/B Ratio
N/A
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
N/A
Current Ratio
N/A
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
N/A
Shares Held By Institutions
N/A
Shares Outstanding - Current
N/A
Total Liabilities
N/A
Total Volume MTD
N/A
Value
N/A
Gain YTD
N/A
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
930 Winter Street
Phone
+1 617 443-2400
Employees
51
Web
https://www.aerovatetx.com